Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol [Pediatric Oncology]

Conclusion Two years after chemotherapy-only treatment, neurocognitive function is largely age appropriate. Nonetheless, survivors remain at elevated risk for attention problems that impact real-world functioning. Attention problems at the end of therapy predicted decreased academics 2 years later, suggesting an amplified functional impact of discrete neurocognitive difficulties. Age at diagnosis and patient sex may alter neurocognitive development in survivors of childhood ALL treated with chemotherapy-only protocols.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Behavioral and Lifestyle Risk Factors, Acute Lymphoblastic Leukemia, Long Term Survival & Late Effects, Outcomes Research, Quality of Life Pediatric Oncology Source Type: research